Man Group plc Cuts Position in Healthpeak Properties, Inc. (NYSE:DOC)

Man Group plc decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 38.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,507,377 shares of the real estate investment trust’s stock after selling 953,071 shares during the quarter. Man Group plc’s holdings in Healthpeak Properties were worth $30,555,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of DOC. JPMorgan Chase & Co. grew its stake in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the period. Vert Asset Management LLC increased its stake in shares of Healthpeak Properties by 11.1% during the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust’s stock worth $6,167,000 after purchasing an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Healthpeak Properties by 25.7% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust’s stock worth $2,213,000 after purchasing an additional 22,300 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Healthpeak Properties by 16.6% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust’s stock valued at $2,217,000 after buying an additional 15,753 shares in the last quarter. Finally, Franklin Resources Inc. acquired a new stake in Healthpeak Properties in the 3rd quarter worth about $3,224,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 1.9%

Shares of NYSE DOC opened at $17.30 on Friday. The company has a market capitalization of $12.02 billion, a P/E ratio of 49.43, a P/E/G ratio of 2.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a 50 day simple moving average of $18.83 and a 200-day simple moving average of $20.11. Healthpeak Properties, Inc. has a 1 year low of $16.90 and a 1 year high of $23.26.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.46. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company’s quarterly revenue was up 15.9% on a year-over-year basis. During the same period last year, the company earned $0.45 EPS. On average, equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th will be given a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date is Monday, May 19th. Healthpeak Properties’s dividend payout ratio is presently 305.00%.

Analysts Set New Price Targets

DOC has been the subject of a number of research analyst reports. Wedbush reduced their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Argus reissued a “buy” rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Evercore ISI lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Scotiabank dropped their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating for the company in a report on Monday. Finally, Robert W. Baird decreased their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $23.25.

Insider Activity

In other news, CEO Scott M. Brinker bought 11,337 shares of the company’s stock in a transaction on Monday, April 28th. The stock was bought at an average cost of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. The trade was a 5.95% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Tommy G. Thompson purchased 5,700 shares of Healthpeak Properties stock in a transaction dated Friday, May 9th. The shares were acquired at an average cost of $17.36 per share, for a total transaction of $98,952.00. Following the transaction, the director now directly owns 138,513 shares of the company’s stock, valued at approximately $2,404,585.68. This represents a 4.29% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 23,987 shares of company stock valued at $422,141. Company insiders own 0.23% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.